Patent Selections:
Journal:
Recent Patents on Biomarkers
Volume:
4
Page:
128-132
Author(s):
Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1530-1541
Author(s):
Irene Paterniti, Marika Cordaro, Michela Campolo, Rosalba Siracusa, Carolin Cornelius, Michele Navarra, Salvatore Cuzzocrea and Emanuela Esposito
Modulation of the FGF14:FGF14 Homodimer Interaction Through Short Peptide Fragments
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1559-1570
Author(s):
Syed Ali, Alexander Shavkunov, Neli Panova, Svetla Stoilova-McPhie and Fernanda Laezza
Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1615-1626
Author(s):
Julio C. Tobon-Velasco, Elvis Cuevas and Mónica A. Torres-Ramos
The Paths to Neurodegeneration in Genetic Parkinson's Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1485-1512
Author(s):
Omar M.E. Abdel-Salam
Toll-Like Receptors in Alzheimer's Disease: A Therapeutic Perspective
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1542-1558
Author(s):
Maria E. Gambuzza, Vincenza Sofo, Francesca M. Salmeri, Luca Soraci, Silvia Marino and Placido Bramanti
Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Journal:
Current Vascular Pharmacology
Volume:
12
Page:
810-817
Author(s):
Debebe Gebremedhin, Sandeep Gopalakrishnan and David R. Harder
Myogenic Tone as a Therapeutic Target for Ischemic Stroke
Journal:
Current Vascular Pharmacology
Volume:
12
Page:
788-800
Author(s):
Sara M. Palomares and Marilyn J. Cipolla
Preface: (Commentary on the Special Issue on the Impact of Myogenic Tone in Health and Disease)
Journal:
Current Vascular Pharmacology
Volume:
12
Page:
779-780
Author(s):
Richard J. Roman and Richard P.E. Van Dokkum
Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
9
Page:
110-121
Author(s):
Kimberley Mander, Elizabeth Harford-Wright, Kate M. Lewis and Robert Vink